Last updated: February 26, 2026
What is the role of excipients in pharmaceuticals?
Excipients are inactive substances incorporated into drug formulations to facilitate manufacturing, stability, absorption, and patient compliance. They include binders, fillers, lubricants, disintegrants, preservatives, and colorants. Excipients account for 90% of a typical drug formulation by weight but do not contribute to therapeutic effects.
How does CARDINAL HEALTH position itself in excipient supply?
Cardinal Health is a leading global healthcare services and products company, supplying a broad range of pharmaceutical excipients. It focuses on sourcing, manufacturing, and distributing excipients aligned with high standards of quality, regulatory compliance, and customer-specific formulations. The company's extensive distribution network facilitates worldwide reach, rapid delivery, and flexible sourcing options.
What is the current market size for pharmaceutical excipients?
The global pharmaceutical excipients market reached USD 9.4 billion in 2022 and is projected to grow at a CAGR of 6.5% through 2030. Growth drivers include rising demand for oral solid dosage forms, the shift towards generic drugs, and increasing consumer preference for controlled-release formulations.
| Year |
Market Size (USD billion) |
CAGR (%) |
| 2022 |
9.4 |
N/A |
| 2025 |
~12.4 |
6.8 |
| 2030 |
~14.9 |
6.5 |
What are strategic areas for excipient development and commercialization?
1. Specialized excipients
Development of high-performance excipients tailored for controlled-release, targeted delivery, and biocompatibility offers differentiation. Examples include hydroxypropyl methylcellulose (HPMC) derivatives for sustained release and lipid-based excipients for oral or injectable formulations.
2. Regulatory compliance and traceability
Providing excipients that meet evolving regulatory standards (FDA, EMA, USP) ensures market access. This includes documentation, lot traceability, and adherence to current Good Manufacturing Practices (cGMP).
3. Sustainable and plant-based excipients
Growing focus on environmental sustainability prompts R&D into biodegradable, plant-derived excipients. These meet consumer demand for "clean-label" drugs and reduce carbon footprints.
4. Custom formulations and co-processed excipients
Offering bespoke excipient blends and co-processed materials allows for improved manufacturing efficiency and product performance. This strategy appeals to brand owners aiming for formulation consistency and reduced process variability.
What commercial opportunities exist?
A. Expanding portfolio through innovation
Investing in R&D for novel excipients positions Cardinal Health to compete in high-growth segments like biologics and personalized medicine.
B. Global regulatory support
Assisting clients with documentation and regulatory submissions accelerates market entry, especially in emerging markets with evolving standards.
C. Partnerships and acquisitions
Forming alliances with excipient manufacturers or acquiring specialty excipient producers enhances technological capabilities and expands geographic reach.
D. Digital and data-driven supply chain
Implementing digital tracking and quality systems increases transparency and reduces supply disruption risks, strengthening customer trust and loyalty.
E. Sustainable sourcing and green chemistry
Aligning procurement with eco-friendly manufacturing practices reduces environmental impact and appeals to environmentally conscious pharmaceutical companies.
How does excipient supply strategy translate into revenue?
Excipients, though inactive, generate significant recurring revenue. Cardinal Health's integrated supply chain, quality assurance, and custom formulation capabilities allow it to command premium pricing for specialized or high-demand excipients. The company's global footprint enables serving both generic and innovative drug manufacturers, diversifying revenue streams.
What are the key challenges?
- Regulatory complexity: Changes in standards affect formulation approval and require continuous compliance updates.
- Supply chain vulnerability: Disruption of raw material sourcing, particularly for plant-based excipients, impacts availability.
- Competitive landscape: Larger players like BASF, Ashland, and Dupont invest heavily in excipient R&D, raising entry barriers.
- Market fragmentation: Diverse customer needs across markets demand tailored strategies, increasing operational complexity.
Key Takeaways
- Excipients are essential to drug formulation, representing a strategic supply segment for Cardinal Health.
- Market expansion hinges on innovation, regulatory support, and sustainability efforts.
- Developing specialized and co-processed excipients offers differentiation in a competitive space.
- Building partnerships and leveraging digital supply chain solutions enhances market positioning.
- Addressing sourcing risks and regulatory hurdles mitigates operational risks.
FAQs
Q1: What are the most common types of pharmaceutical excipients?
Binders, disintegrants, lubricants, fillers, and preservatives are the most common, each serving a specific role in formulation integrity and performance.
Q2: How does sustainability influence excipient development?
Sustainable excipients, derived from renewable resources, align with industry shifts towards eco-friendly practices and meet increasing regulatory and consumer demands.
Q3: What regulatory standards must excipients meet?
Excipients must comply with USP, EP, JP, and FDA standards for identity, purity, and safety. Documentation includes Certificates of Analysis (CoA) and lot traceability records.
Q4: How significant is innovation in excipient markets for Cardinal Health?
Innovation drives differentiation and access to high-value segments, such as biologics and personalized therapies, making it critical for competitiveness.
Q5: What steps can Cardinal Health take to capitalize on excipient market growth?
Investing in R&D, expanding co-processed excipient offerings, strengthening regulatory support, and forming strategic partnerships enhance market share.
References
- Grand View Research. (2023). Pharmaceutical Excipients Market Size, Share & Trends Analysis Report. Retrieved from https://www.grandviewresearch.com/industry-analysis/pharmaceutical-excipients-market
- U.S. Food and Drug Administration. (2020). Guidance for Industry: Excipients in Drug Products.
- MarketsandMarkets. (2022). Excipients Market by Source, Type, Function, and Application.
- Bloomberg Intelligence. (2023). Pharmaceutical Inputs: Market Outlook and Competitive Strategies.
- International Pharmaceutical Excipients Council. (2022). Regulatory & Sustainability Standards.
